Impaired Endothelial Progenitor Cell Activity is Associated with Reduced Arterial Elasticity in Patients with Essential Hypertension

REFERENCES

• Cohn JN. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation 2006;113:601–603.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Duprez DA, Grandits GA. Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. Hypertension 2005;46:217–220.
   PubMed Web of Science ®Google Scholar
• Franklin SS. Arterial stiffness and hypertension: a two-way street? Hypertension 2005;45: 349–351.
   PubMed Web of Science ®Google Scholar
• Laurent S. Surrogate measures of arterial stiffness: do they have additive predictive value or are they only surrogates of a surrogate? Hypertension 2006;47:325–326.
   PubMed Web of Science ®Google Scholar
• Abdelhammed AI, Smith RD, Levy P, Smits GJ, and Ferrario CM. Noninvasive hemodynamic profiles in hypertensive Subjects. Am J Hypertens 2005;18:51S–59S.
   PubMed Web of Science ®Google Scholar
• Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932–943.
   PubMed Web of Science ®Google Scholar
• Boos CJ, Goon PKY and Lip GYH. Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more. J Hum Hypertens 2006; 21:521–523.
   Google Scholar
• Wilson AM, Neal DO, Nelson CL, Prior DL, Best JD, and Jenkins AJ. Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens 2004; 17:285–291.
   PubMed Web of Science ®Google Scholar
• Aicher A, Andreas MZ, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005;45:321.
   PubMed Web of Science ®Google Scholar
• Wang JM, Huang YJ, Wang Y, Xu MG, Wang LC, Wang SM, Tao J. Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens 2007;20:957–964.
   PubMed Web of Science ®Google Scholar
• Tao J, Wang Y, Yang Z, Tu C, Xu MG, Wang JM. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. J Hum Hypertens 2006;20:490–495.
   PubMed Web of Science ®Google Scholar
• Imanishi T, Moriwaki C, Hano T and Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005;23:1831–1837.
   PubMed Web of Science ®Google Scholar
• Hill, JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003; 348: 593–600.
   PubMed Web of Science ®Google Scholar
• Pirro M, Schillac G, Menecali C, Bagaglia F, Paltriccia R, Vaudo G, Mannarino MR, and Mannarino E. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens 2007;25:2093–2099.
   PubMed Web of Science ®Google Scholar
• Zonneveld Anton-Jan van and Rabelink TJ. Endothelial progenitor cells: biology and therapeutic potential in hypertension. Curr Opinion Nephrol Hypertens 2006;15:167–172.
   PubMed Web of Science ®Google Scholar
• Yao EH, Fukuda N, Natsumoto T, Katakawa M, Yamamoto C, Han Y, Ueno T, Kobayashi N, Katakawa K. Effects of the antioxidative beta-blocker celiprolol on endothelial progenitor cells in hypertensive rats. Am J Hypertens 2008;21: 1062–1068.
   PubMed Web of Science ®Google Scholar
• Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L, Spyridopoulos I, Zeiher AM, Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003;92:1049–1055.
   PubMed Web of Science ®Google Scholar
• Ablin JN, Boquslavski V, Aloush V, Elkayam O, Paran D, Caspi D, George J. Effect of anti-TNF alpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 2006;79:2364–2369.
   PubMed Web of Science ®Google Scholar
• Colleselli D, Bijuklic K, Mosheimer BA, Kahler CM. Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res 2006;312:2933–2941.
   PubMed Web of Science ®Google Scholar
• McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, Cohn JN. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis; aging and arterial compliance. Hypertension 1999;33:1392–1398.
   PubMed Web of Science ®Google Scholar
• Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003;16:653–657.
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher A, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:e1–e7.
   PubMed Web of Science ®Google Scholar
• Tao J, Yang Z, Wan JM, Tu C, Pan SR. Effects of fluid shear stress on eNOS mRNA expression and NO production in human endothelial progenitor cells. Cardiology 2006;2: 82–88.
   Google Scholar
• Yang Z, Tao J, Wang JM, Tu C, Xu MG, Wang Y, Pan SR. Shear stress contributes to t-PA mRNA expression in human endothelial progenitor cells and nonthrombogenic potential of small diameter artificial vessels. Biochem Biophys Res Commun 2006;342:577–584.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang JM, Wang LC, Chen L, Tu C, Luo CF, Tang AL, Wang SM, Tao J. In vitro shear stress modulates antithrombogenic potentials of human endothelial progenitor cells. J Thromb Thromboly 2007;23:121–127.
   PubMed Web of Science ®Google Scholar
• Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441–1448.
   PubMed Web of Science ®Google Scholar
• Sandri MB, Adams V, Gielen S, Linke A, Lenk K, Kränkel N, Lenz D, Erbs S, Scheinert D, Mohr FW, Schuler G, Hambrecht R. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: Results of 3 randomized studies. Circulation 2005;111:3391–3399.
   PubMed Web of Science ®Google Scholar
• Rietzschel ER, Boeykens E, Buyzere ML, Duprez DA, Clement DL. A comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness. Hypertension 2001;37:15–22.
   Google Scholar
• Yu WC, Chuang SY, Lin YP, Chen CH. Brachial-ankle vs carotid-femoral pulse wave velocity as a determinant of cardiovascular structure and function. J Hum Hypertens 2008;22: 24–31.
   PubMed Web of Science ®Google Scholar
• Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008; 197:496–503.
   PubMed Web of Science ®Google Scholar
• Oliveras A, Soler MJ, Martinez-Estrade OM, Vazquez S, Macro-Feliu D, Vila JS, Vilaro S, Lloveras J. Endothelial progenitor cells are reduced in refractory hypertension. J Hum Hypertens 2007;28:721–727.
   Google Scholar
• Delva P, Degan M, Vallerio P, Arosio E, Minuz P, Amen G, Chio M D, and Lechi A. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 2007; 25:127–132.
   PubMed Web of Science ®Google Scholar
• Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2004;18:203–209.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang JM, Chen L, Luo CF, Tang AL, and Tao J. Acute exercise-induced nitric oxide production contributes to upregulation of circulating endothelial progenitor cells in healthy subjects. J Hum Hypertens 2007;21:452–460.
   PubMed Web of Science ®Google Scholar
• Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997;349:837–842.
   PubMed Web of Science ®Google Scholar
• Alexandra A, Christopher, H and Dimmeler S. The role of NOS3 in stem cell Mobilization. Trends In Mol Med 2004; 10:421–425.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/ NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916–1923.
   PubMed Web of Science ®Google Scholar
• Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005;23:97–104.
   PubMed Web of Science ®Google Scholar
• Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, and Lip GYH. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am J Cardiol 2001;87:805–807.
   PubMed Web of Science ®Google Scholar